Affinity Asset Advisors »

Autolus Therapeutics Plc spon ads shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.6M 2.0M 2.33
2023-06-30 $3.8M 1.6M 2.38

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads